Atricure, Inc. (ATRC) Tops Q2 EPS by 3c, Boosts FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Piper Jaffray Raises Price Target on Atricure, Inc. (ATRC) to $30 Following 2Q Results
July 29, 2015 10:10 AM EDTPiper Jaffray reiterated an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and raised the price target to $30.00 (from $23.00), following 2Q15 results. ATRC reported Q2 sales of $32.6M, and EPS of -$0.18, beating out consensus on both metrics. Analyst Thomas Gunderson believes that... More



